Reduced Costs and Continued Cures Act [HB-5260]
[Healthcare ]
[Medicare and Medicaid ]
[Pharmaceuticals ]
[Consumer Protection ]
[Public Health ]
To amend titles XI, XVIII, and XIX of the Social Security Act to lower prescription drug prices in the Medicare and Medicaid programs, to improve transparency related to pharmaceutical prices and transactions, to lower patients' out-of-pocket costs, and to ensure accountability to taxpayers, and for other purposes.
HB-5260: Reduced Costs and Continued Cures Act
Sponsored by: Rep. Luis Correa
Referred To The Subcommittee On Antitrust, Commercial, And Administrative Law. on 11/01/2022
Reduced Costs and Continued Cures Act of 2021 [HB-5237]
[Healthcare ]
[Medicare and Medicaid ]
[Pharmaceuticals ]
[Consumer Protection ]
[Public Health ]
[Senior Citizens ]
To amend titles XI, XVIII, and XIX of the Social Security Act to lower prescription drug prices in the Medicare and Medicaid programs, to improve transparency related to pharmaceutical prices and transactions, to lower patients' out-of-pocket costs, and to ensure accountability to taxpayers, and for other purposes.
HB-5237: Reduced Costs and Continued Cures Act of 2021
Sponsored by: Rep. Luis Correa
Referred To The Subcommittee On Antitrust, Commercial, And Administrative Law. on 11/01/2022
Lowering Medicare Premiums and Prescription Drug Costs Act [HB-5099]
[Healthcare ]
[Medicare and Medicaid ]
[Pharmaceuticals ]
[Senior Citizens ]
[Social Security ]
To amend title XVIII of the Social Security Act to move Medicare cost-sharing benefits from Medicaid to Medicare, and for other purposes.
HB-5099: Lowering Medicare Premiums and Prescription Drug Costs Act
Sponsored by: Rep. Janice Schakowsky
Referred To The Subcommittee On Health. on 08/24/2021
You have voted HB-4981: To amend the Fentanyl Sanctions Act, to modify certain deadlines relating to the Commission on Combating Synthetic Opioid Trafficking..
Quit Because of COVID–19 Act [S.2622]
[Healthcare ]
[Medicare and Medicaid ]
[Public Health ]
A bill to amend title XIX and XXI of the Social Security Act to provide coverage of comprehensive tobacco cessation services under such titles, and for other purposes.
S.2622: Quit Because of COVID–19 Act
Sponsored by: Sen. Susan Collins
Read Twice And Referred To The Committee On Finance. on 08/05/2021
Securing America’s Medicine Cabinet Act of 2021 [S.2589]
[Pharmaceuticals ]
[Healthcare ]
[Manufacturing ]
[Education ]
[Technology and Innovation ]
[Science ]
[Economic Development ]
A bill to amend the 21st Century Cures Act to provide for designation of institutions of higher education that provide research, data, and leadership on advanced and continuous manufacturing as National Centers of Excellence in Continuous Pharmaceutical Manufacturing, and for other purposes.
S.2589: Securing America’s Medicine Cabinet Act of 2021
Sponsored by: Sen. Robert Menendez
Read Twice And Referred To The Committee On Health, Education, Labor, And Pensions. on 08/03/2021
Protecting our Pharmaceutical Supply Chain from China Act of 2021 [S.2495]
[Pharmaceuticals ]
[Healthcare ]
[Trade ]
[National Security ]
[Funding ]
A bill to require the Secretary of Health and Human Services to maintain a list of the country of origin of all drugs marketed in the United States, to ban the use of Federal funds for the purchase of drugs manufactured in the People's Republic of China, and for other purposes.
S.2495: Protecting our Pharmaceutical Supply Chain from China Act of 2021
Sponsored by: Sen. Marsha Blackburn
Read Twice And Referred To The Committee On Finance. on 07/28/2021
HCR-42: Expressing the sense of Congress that governmental entities should use a portion of the proceeds from litigation against opioid manufacturers and distributors to increase participation in drug take back programs and for the safe disposal of collected, unused medicines.
Sponsored by: Rep. Mark DeSaulnier
Referred To The Subcommittee On Health. on 07/22/2021
You have voted HCR-42: Expressing the sense of Congress that governmental entities should use a portion of the proceeds from litigation against opioid manufacturers and distributors to increase participation in drug take back programs and for the safe disposal of collected, unused medicines..
Seniors Prescription Drug Relief Act [S.2327]
[Healthcare ]
[Medicare and Medicaid ]
[Senior Citizens ]
[Pharmaceuticals ]
A bill to amend title XVIII of the Social Security Act to provide for a Medicare part D modernization redesign and to establish a monthly out-of-pocket cost sharing maximum for enrollees who incur a significant portion of costs towards the annual out-of-pocket threshold under Medicare part D.
S.2327: Seniors Prescription Drug Relief Act
Sponsored by: Sen. Robert Menendez
Read Twice And Referred To The Committee On Finance. on 07/13/2021
National Centers of Excellence in Advanced and Continuous Pharmaceutical Manufacturing Act of 2021 [HB-4369]
[Pharmaceuticals ]
[Healthcare ]
[Manufacturing ]
[Science ]
[Technology and Innovation ]
[Education ]
To amend the 21st Century Cures Act to provide for designation of institutions of higher education that provide research, data, and leadership on continuous manufacturing as National Centers of Excellence in Continuous Pharmaceutical Manufacturing, and for other purposes.
HB-4369: National Centers of Excellence in Advanced and Continuous Pharmaceutical Manufacturing Act of 2021
Sponsored by: Rep. Frank Pallone
Received In The Senate And Read Twice And Referred To The Committee On Health, Education, Labor, And Pensions. on 10/20/2021
Lower Costs, More Cures Act of 2021 [S.2164]
[Healthcare ]
[Medicare and Medicaid ]
[Pharmaceuticals ]
[Senior Citizens ]
A bill to provide for certain reforms with respect to the Medicare program under title XVIII of the Social Security Act, and for other purposes.
S.2164: Lower Costs, More Cures Act of 2021
Sponsored by: Sen. Roger Marshall
Read Twice And Referred To The Committee On Finance. on 06/22/2021
RAISE Act Renal Anemia Innovation Support and Expansion Act [HB-2934]
[Healthcare ]
[Medicare and Medicaid ]
[Pharmaceuticals ]
[Senior Citizens ]
To amend title XVIII of the Social Security Act to remove from the list of drugs excluded from coverage under the Medicare prescription drug program prescription oral vitamins and mineral products indicated for the treatment of iron deficiency anemia in individuals with chronic kidney disease.
HB-2934: RAISE Act Renal Anemia Innovation Support and Expansion Act
Sponsored by: Rep. Tom O'Halleran
Referred To The Subcommittee On Health. on 04/30/2021
Department of Veterans Affairs Provider Accountability Act [S.2041]
[Veterans ]
[Healthcare ]
[Law Enforcement ]
A bill to amend title 38, United States Code, to direct the Secretary of Veterans Affairs to enforce the licensure requirement for medical providers of the Department of Veterans Affairs.
S.2041: Department of Veterans Affairs Provider Accountability Act
Sponsored by: Sen. Susan Collins
Committee On Veterans' Affairs. Ordered To Be Reported Without Amendment Favorably. on 07/28/2021
Compensation for Americans Act of 2021 [HB-3882]
[International ]
[Healthcare ]
[Public Health ]
To initiate negotiations for a bilateral agreement on compensation between the United States and the People's Republic of China relating to the spread of the virus responsible for COVID-19, and for other purposes.
HB-3882: Compensation for Americans Act of 2021
Sponsored by: Rep. Brian Babin
Referred To The Subcommittee On Health. on 06/15/2021
Promising Pathway Act [HB-3761]
[Healthcare ]
[Pharmaceuticals ]
To amend the Federal Food, Drug, and Cosmetic Act to establish a time-limited provisional approval pathway, subject to specific obligations, for certain drugs and biological products, and for other purposes.
HB-3761: Promising Pathway Act
Sponsored by: Rep. Mike Quigley
Referred To The Subcommittee On Health. on 06/09/2021